Holiday Sale | Save 50%
SubscribeLogin
Holiday Sale | Save 50%
Published

InspireMD Announces First Patient Enrolled in CGUARDIANS II Pivotal Study

Summary by ETF Daily News
InspireMD, Inc., a leading medical technology company, recently disclosed in an 8-K filing with the Securities and Exchange Commission that the first patient has been successfully enrolled in its CGUARDIANS II clinical trial. This study aims to evaluate the application of the CGuard Prime Carotid Stent System in patients undergoing carotid artery stenting through the […]
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

MarylandMaryland
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal